Richter may postpone guidance pending Esmya review (0)

Magyarország BBJ 2 weeks ago 31
Hungarian drugmaker Gedeon Richter may hold off on guidance when it publishes fourth-quarter earnings in February if uncertainty continues surrounding Esmya, its drug for the treatment of uterine cysts, CEO Gábor Orbán told news wire Reuters late Friday. 
Read The Rest at BBJ Back to news

NB! Comments are published by the readers.
Accept rules.

Comments (0)

Please Insert Your Name Please Write Your Comment Error Happened